The Journal of Organic Chemistry
Article
as an oil. Solvent evaporation gave a white solid, which was
recrystallized from DCM/pentane to afford the product as a white
crystalline powder (321 mg, 0.6 mmol, 47%). mp 53−54 °C. 1H
NMR (300 MHz, CDCl3): δ 8.27 (m, 1H), 7.89 (m, 2H), 7.20 (m,
1H), 3.41 (t, JH−H = 7 Hz, 2H), 2.91 (t, JH−H = 7 Hz, 2H), 1.85 (m,
2H), 1.72 (m, 2H), 1.44−1.26 (brm, 22H) ppm. 13C{1H} NMR (75
MHz, CDCl3): δ 199.2, 141.7, 139.0, 137.2, 130.4, 127.3, 94.6, 38.7,
34.2, 33.0, 29.74, 29.72, 29.70, 29.59, 29.56, 29.4, 28.9, 28.3, 24.3
ppm. MS (APCI) m/z: 431 [M + H]+ (100%). HRMS (APCI) m/z:
[M + H]+ Calcd for C22H35BrIO 521.0911, found 521.0910.
mL, 6.9 mmol) as described by the general procedure above. A
solution of the acid chloride in dichloromethane (20 mL) and
aluminum(III) chloride (306 mg, 2.3 mmol) was added to 1h (1.2 g,
2.3 mmol) in dichloromethane (20 mL) using a syringe pump.
Aqueous workup and flash filtration through KF/silica gave the crude
product as an oil. Purification was achieved by flash chromatography
on silica using hexane/ethyl acetate (9:1) as the eluent to afford the
1
product as a colorless oil (0.773 g, 1.9 mmol, 84%). H NMR (300
MHz, CDCl3): δ 7.67−7.63 (m, 2H), 7.55−7.43 (m, 2H), 7.37−7.20
(m, 4H), 2.48 (m, 2H), 1.49 (m, 2H), 1.23−1.16 (brm, 14H), 0.88 (t,
11-Bromo-1-(2-bromophenyl)undecan-1-one (2m). 11-Bro-
moundecanoic acid (1.19 g, 4.5 mmol) was converted to the
corresponding acid chloride in dichloromethane (10 mL) using oxalyl
dichloride (1.1 mL, 13.5 mmol) as described by the general procedure
above. A solution of the acid chloride in dichloromethane (40 mL)
and aluminum(III) chloride (598 mg, 4.5 mmol) was added to 1g
(2.00 g, 4.5 mmol) in dichloromethane (40 mL) using a syringe
pump. Aqueous workup, flash filtration through KF/silica and solvent
evaporation gave the crude product as an oil, which was recrystallized
from pentane with the aid of an acetone/dry ice cooling bath. The
compound was dissolved in pentane (∼50 mL) in a round-bottom
flask equipped with rubber septum and a canula with fitted filter
paper, then placed into the cooling bath the flask was gently shaken.
This quickly led to the formation of a white precipitate. The cold
pentane solution was removed through the canula by applying N2
pressure. The obtained solids were redissolved in pentane, and the
procedure was repeated twice. The product was obtained crystalline
solid, which melted to a colorless oil at room temperature (882 mg,
2.2 mmol, 49%). 1H NMR (300 MHz, CDCl3): δ 7.61−7.58 (m, 1H),
7.36−7.34 (m, 2H), 7.30−7.24 (m, 1H), 3.40 (t, JH−H = 7 Hz, 2H),
2.90 (t, JH−H = 7 Hz, 2H), 1.85 (m, 2H), 1.70 (m, 2H), 1.44−1.29
(brm, 12H) ppm. 13C{1H} NMR (75 MHz, CDCl3): δ 204.3, 142.0,
133.5, 131.3, 128.2, 127.3, 118.5, 42.7, 34.0, 32.8, 29.29, 29.27, 29.25,
29.0, 28.7, 28.1, 24.0 ppm. MS (APCI) m/z: 405 [M + H]+ (100%).
HRMS (APCI) m/z: [M + H]+ Calcd for C17H25Br2O 403.0267,
found 403.0267.
J
H−H = 7 Hz, 3H). 13C{1H} NMR (75 MHz, CDCl3): δ 204.8, 142.1,
140.0, 139.7, 132.8, 131.3, 131.2, 130.6, 129.2, 128.1, 128.0, 127.4,
123.0, 41.7, 32.0, 29.7, 29.6, 29.4, 29.2, 24.3, 22.8, 14.2 ppm. MS
(APCI) m/z: 403 [M + H]+ (100%). HRMS (APCI) m/z: [M + H]+
Calcd for C23H30BrO 401.1475, found 401.1475.
11-Bromo-1-(4′-bromo-[1,1′-biphenyl]-4-yl)undecan-1-one (2p).
11-Bromoundecanoic acid (508 mg, 1.9 mmol) was converted to the
corresponding acid chloride in dichloromethane (8 mL) using oxalyl
dichloride (0.5 mL, 5.7 mmol) as described by the general procedure
above. A solution of the acid chloride in dichloromethane (17 mL)
and aluminum(III) chloride (255 mg, 1.9 mmol) was added to 1i (1.0
g, 1.9 mmol) in dichloromethane (17 mL) using a syringe pump.
Aqueous workup and flash filtration through KF/silica gave the crude
product as an oil. Solvent evaporation gave a white crystalline solid,
which was recrystallized from DCM/pentane to afford the product as
a white crystalline powder (497 mg, 1.0 mmol, 54%). mp 115−116
1
°C. H NMR (300 MHz, CDCl3): δ 8.02 (dm, JH−H = 9 Hz, 2H),
7.63 (dm, JH−H = 9 Hz, 2H), 7.59 (dm, JH−H = 9 Hz, 2H), 7.48 (dm,
JH−H = 9 Hz, 2H), 3.40 (t, JH−H = 7 Hz, 2H), 2.98 (t, JH−H = 7 Hz,
2H), 1.85 (m, 2H), 1.75 (m, 2H), 1.44−1.30 (brm, 12H) ppm.
13C{1H} NMR (75 MHz, CDCl3): δ 200.2, 144.4, 138.9, 136.2, 132.2,
128.9, 128.9, 127.1, 122.7, 38.8, 34.2, 32.9, 29.6, 29.50, 29.486,
29.470, 28.9, 28.3, 24.5 ppm. MS (APCI) m/z: 481 [M + H]+
(100%). HRMS (APCI) m/z: [M + H]+ Calcd for C23H29Br2O
479.0580, found 479.0582.
11-Bromo-1-(2′-bromo-[1,1′-biphenyl]-2-yl)undecan-1-one (2n).
11-Bromoundecanoic acid (762 mg, 2.9 mmol) was converted to the
corresponding acid chloride in dichloromethane (10 mL) using oxalyl
dichloride (0.7 mL, 8.6 mmol) as described by the general procedure
above. A solution of the acid chloride in dichloromethane (25 mL)
and aluminum(III) chloride (383 mg, 2.9 mmol) was added to 1h
(1.5 g, 2.9 mmol) in dichloromethane (25 mL) using a syringe pump.
Aqueous workup and flash filtration through KF/silica gave the crude
product as an oil. Purification was achieved by flash chromatography
on silica using hexane/ethyl acetate (9:1) as the eluent, affording the
NMR Scale Reactions. 11-Bromoundecanoic acid (1.0 g, 5.4
mmol) was converted to the corresponding acid chloride in
dichloromethane (10 mL) using oxalyl dichloride (1.4 mL, 16.1
mmol) as described by the general procedure above. The acid
chloride was dried under high vacuum, kept under Ar, and used for all
NMR-scale test reactions. On a small scale (0.8 mL) for an NMR
experiment, a slow addition (1h) of acylium surprisingly resulted in
the formation of substantially more halobenzene compared to a fast
addition (5 min) and a slow addition on a preparative scale (50 mL).
When the addition was performed over 1 h, the ratio of 2a−AlCl3/
fluorobenzene was 35:65 based on the integrations of the aromatic 1H
NMR resonances. The amount of the desired product 2a−AlCl3
substantially increased when the addition was conducted over only 5
min, giving a ratio of 88:11. Similar results were observed for the
chloro derivative 2b−AlCl3, with the ratio of 2b−AlCl3 to
chlorobenzene being 13:87 when the acylium species was added
over 1 h and increasing to 72:28 when the addition was conducted
over 5 min. Based on these observations, the acylium species was
added over 5 min for all NMR-scale reactions. The discrepancies of
the product distribution are most likely attributed to the
concentration of acylium in the reaction vessel and the drop size.
For all additions, we used needles of the same gauge size. Thus, when
1
product as a colorless oil (1.226 g, 2.6 mmol, 86%). H NMR (400
MHz, CDCl3): δ 7.67−7.61 (m, 2H), 7.50−7.40 (m, 2H), 7.34−7.30
(m, 1H), 7.25−7.18 (m, 3H), 3.37 (t, JH−H = 7 Hz, 2H), 2.51 (m,
2H), 1.82 (m, 2H), 1.50 (m, 2H), 1.40 (m, 2H), 1.24−1.17 (brm,
10H) ppm. 13C{1H} NMR (101 MHz, CDCl3): δ 204.0, 141.8, 139.6,
139.4, 132.5, 131.0, 130.9, 130.4, 128.9, 127.9, 127.7, 127.1, 122.7,
41.3, 33.8, 32.7, 29.2, 29.13, 29.09, 28.9, 28.6, 28.0, 24.0 ppm. MS
(APCI) m/z: 481 [M + H]+ (100%). HRMS (APCI) m/z: [M + H]+
Calcd for C23H29Br2O 479.0580, found 479.0582.
1-(2′-Bromo-[1,1′-biphenyl]-2-yl)undecan-1-one (2o). Undeca-
noic acid (428 mg, 2.3 mmol) was converted to the corresponding
acid chloride in dichloromethane (8 mL) using oxalyl dichloride (0.6
9018
J. Org. Chem. 2021, 86, 9007−9022